Structure of Sodium 4-Phenylbutyrate
CAS No.: 1716-12-7
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Sodium 4-phenylbutyrate (4-PBA sodium) is an inhibitor of HDAC and endoplasmic reticulum (ER) stress, utilized in cancer and infection research.
Synonyms: 4-PBA sodium; 4-Phenylbutyric acid sodium; TriButyrate
4.5
*For Research Use Only !
Change View
| Size | Price | VIP Price |
DE Stock US Stock |
Asia Stock Global Stock |
In Stock |
| {[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock Inquiry - | Login - + |
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
| CAS No. : | 1716-12-7 |
| Formula : | C10H11NaO2 |
| M.W : | 186.18 |
| SMILES Code : | O=C([O-])CCCC1=CC=CC=C1.[Na+] |
| Synonyms : |
4-PBA sodium; 4-Phenylbutyric acid sodium; TriButyrate
|
| MDL No. : | MFCD00800247 |
| InChI Key : | VPZRWNZGLKXFOE-UHFFFAOYSA-M |
| Pubchem ID : | 5258 |
| GHS Pictogram: |
|
| Signal Word: | Warning |
| Hazard Statements: | H319 |
| Precautionary Statements: | P305+P351+P338 |
| Target |
|
In Vitro:
| Concentration | Treated Time | Description | References |
| rat heart cells | 10 mM | 30 min | relieves ER stress and improves contractile function | J Am Heart Assoc. 2013 May 17;2(3):e004796. |
| MDA-MB-231 cells | 20 μM | 24 h | Reduce UPR activation and protect cells from apoptosis | Cell Death Dis. 2013 Jul 18;4(7):e732. |
| HeLa cells | 5 mM | 4 h | To evaluate the effect of 4-PBA on GRP78 protein levels and caspase-12 activity. 4-PBA significantly reduced the increase of GRP78 induced by δ-T3 and TRF treatment and significantly inhibited the γ-T3- and δ-T3-induced increase of caspase-12 activity. | Genes Nutr. 2016 Dec 23;11:32. |
| bone marrow-derived early outgrowth cells (EOCs) | 50 μM | 7 days | To investigate the effect of ER stress on EOC function under high glucose conditions, 4-phenylbutyrate significantly alleviated HG-induced ER stress, apoptosis, and functional impairment. | Diabetologia. 2015 Sep;58(9):2181-90. |
| Tomato plant leaves | 1 mM | 6 h | To evaluate how a chemical chaperone modulates Tm-induced ER stress, it was found that it decreased the Tm-induced increase in SlBiP, SlIRE1a, and SlBI1 transcripts | Biomolecules. 2020 Jul 10;10(7):1031. |
| Human Brain Microvascular Endothelial Cells (HBMECs) | 10 μM | 1 h | Inhibition of Tat-induced ER stress and apoptosis | Mol Neurobiol. 2016 Jan;53(1):132-142. |
| ND1-mutant cybrids | 1 mM | 48 h | To investigate the protective effects of 4-Phenylbutyrate on ND1-mutant cells under energetic stress conditions. Results showed that 4-Phenylbutyrate partially attenuated the expression of ER stress markers such as Bip/GRP78, CHOP, and sXBP1 mRNA levels. | Cell Death Dis. 2018 May 31;9(6):658. |
| NIH-3T3 cells | 20 μM | 24/48 h | Increase cell folding capacity, reduce UPR activation, and protect transformed cells from death | Cell Death Dis. 2013 Jul 18;4(7):e732. |
| human hepatocytes (from OTCD patients) | 0.01, 0.1, and 1 mM | 2 weeks | To evaluate the effect of 4-PB and SB on reducing ammonia levels in hepatocytes from OTCD patients. Results showed that 4-PB treatment was more effective than SB, and hetero-OTCD hepatocytes were more susceptible than hemi-OTCD hepatocytes. | J Inherit Metab Dis. 2021 May;44(3):618-628. |
In Vivo:
| Administration | Dosage | Frequency | Description | References |
| ApoE-/- mice | 5/6 nephrectomy-induced chronic kidney disease model | Intraperitoneal injection | 250 mg/kg | Once daily for 8 weeks | To investigate the effect of 4-PBA on CKD-dependent vascular calcification. Results showed that 4-PBA treatment significantly reduced aortic calcified lesions. | J Am Heart Assoc. 2013 Sep 5;2(5):e000238 |
| Rats | Neonatal ventral hippocampal lesion model | Subcutaneous injection | 20 mg/kg | Daily from the day after surgery until adulthood (week 9) | To investigate whether the HDAC inhibitor phenylbutyrate could counteract long-term consequences of neonatal ventral hippocampal lesions in rats. Results showed that phenylbutyrate treatment reduced hypersensitivity of the dopaminergic system and deterioration of associative learning, but did not affect anxiety or anatomical brain changes. | Front Psychiatry. 2011 Jan 7;1:153 |
Clinical Trial:
| NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
| NCT00999167 | Cirrhosis Hep... More >>atic Encephalopathy Less << | Phase 2 | Completed | - | - |
| NCT01135680 | Drug Toxicity | Phase 1 | Completed | - | United States, Wisconsin ... More >> Covance Clinical Pharmacology, Inc. Madison, Wisconsin, United States, 53704 Less << |
| NCT00999167 | - | Completed | - | - | |
| NCT01347073 | Urea Cycle Disorders | Phase 3 | Completed | - | United States, California ... More >> UCLA Pediatrics/Genetics Los Angeles, California, United States, 90404 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Maine Maine Medical Center Portland, Maine, United States, 04101 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 United States, Ohio University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 Less << |
| NCT01948427 | - | Recruiting | September 2026 | United States, Pennsylvania ... More >> United BioSource Corporation Recruiting Blue Bell, Pennsylvania, United States, 19422 Contact: THRIVE Registry Team 855-823-2595 thriveregistry@unitedbiosource.com Less << | |
| NCT03488524 | Amyotrophic Lateral Sclerosis ... More >> ALS Less << | Phase 2 | Recruiting | January 1, 2020 | United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Aileen Shaughnessy, MA 617-724-9196 ANSHAUGHNESSY@mgh.harvard.edu Principal Investigator: James Berry, MD University of Massachusetts Memorial Medical Center Recruiting Worcester, Massachusetts, United States, 01655 Contact: Diane McKenna-Yasek, RN, BSN 508-856-4697 diane.mckenna-yasek@umassmed.edu Principal Investigator: Margaret Owegi, DO Less << |
| NCT00067756 | Alpha 1-Antitrypsin Deficiency | PHASE2 | COMPLETED | 2025-10-03 | University of Florida, Gainesv... More >>ille, Florida, 32610, United States Less << |
| NCT02094222 | - | - | - | - | |
| NCT00947297 | - | Completed | - | - | |
| NCT00771901 | - | Completed | - | - | |
| NCT01347073 | - | Completed | - | - | |
| NCT01257737 | Urea Cycle Disorders | Phase 4 | Completed | - | United States, California ... More >> UCLA Pediatrics/Genetics Los Angeles, California, United States, 90095 Stanford University School of Medicine Palo Alto, California, United States, 94305 United States, Colorado Denver Children's Hospital Aurora, Colorado, United States, 80045 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Maine Maine Medical Center Portland, Maine, United States, 04102 United States, Minnesota University of Minnesota Medical Center Minneapolis, Minnesota, United States, 55454 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 United States, Ohio University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Pennsylvania Children's Hospital of Pittsburg of UPMC Pittsburgh, Pennsylvania, United States, 15224 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Utah University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 United States, Wisconsin Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53226 Canada, Ontario The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less << |
| NCT00771901 | Insulin Resistance ... More >> Diabetes Obesity Less << | Not Applicable | Completed | - | United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less << |
| NCT00004767 | Amino Acid Metabolism, Inborn ... More >>Errors Less << | Phase 2 | Completed | - | - |
| NCT00947297 | Urea Cycle Disorders | Phase 3 | Completed | - | - |
| NCT03533257 | Alzheimer Disease | Phase 2 | Recruiting | September 1, 2020 | United States, Illinois ... More >> Rush University Medical Center Recruiting Chicago, Illinois, United States, 60612 Contact: Judy Phillips 312-942-0050 Judy_Phillips@rush.edu United States, Kansas University of Kansas Clinical Research Center Recruiting Fairway, Kansas, United States, 66205 Contact: KUMC Recruitment Division 913-588-0555 KUAMP@kumc.edu United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Alison J McManus, DNP 617-643-4848 ajmcmanus@mgh.harvard.edu Contact: John Ernandez 617-643-4047 jernandez@partners.org United States, New Jersey Rowan University Not yet recruiting Stratford, New Jersey, United States, 08084 Contact: Lauren Fedor 856-566-6003 fedor@rowan.edu United States, New York Mount Sinai Alzheimer's Disease Research Center Not yet recruiting New York, New York, United States, 10029 Contact: Caroline Meuser 212-659-8885 caroline.meuser@mssm.edu Columbia University Recruiting New York, New York, United States, 10032 Contact: Ruth Tejeda 212-305-7661 rbt41@cumc.columbia.edu United States, Pennsylvania Penn Memory Center Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Laura Schankel 215-349-8727 laura.schankel@pennmedicine.upenn.edu Less << |
| NCT00006239 | Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << | Phase 1 | Completed | - | United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less << |
| NCT01257737 | - | Completed | - | - | |
| NCT00986895 | Hepatic Encephalopathy ... More >> Urea Cycle Disorders Less << | Phase 1 | Completed | - | Ukraine ... More >> National University of Pharmacy Kharkiv, Ukraine, 61057 Department of General Surgery #2; Kharkiv State Medical University Kharkiv, Ukraine, 61128 Less << |
| NCT00387530 | Gastric Cancer ... More >> Head and Neck Cancer Lymphoma Lymphoproliferative Disorder Less << | Phase 2 | Unknown | - | United States, California ... More >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 Less << |
| NCT00005934 | Beta Thalassemia | Phase 2 | Completed | - | United States, Maryland ... More >> National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States, 20892 Less << |
| NCT03127514 | Amyotrophic Lateral Sclerosis ... More >> Motor Neuron Disease Neuromuscular Diseases Neurodegenerative Diseases Spinal Cord Diseases TDP-43 Proteinopathies Nervous System Diseases Central Nervous System Diseases Less << | Phase 2 | Recruiting | May 2019 | - |
| NCT02343094 | Proteinuric Diseases | Phase 2 Phase 3 | Completed | - | France ... More >> Hôpital Necker Enfants Malades Paris, France, 75015 Less << |
| NCT02246218 | Urea Cycle Disorder | Phase 4 | Completed | - | United States, California ... More >> Kaiser Permanente Regional Metabolic Center Los Angeles, California, United States, 90027 Stanford Center for Clinical & Translational Research & Education Palo Alto, California, United States, 94034 United States, District of Columbia Children's National Medical Center Washington, D.C., District of Columbia, United States, 20010 United States, Florida Shands at University of Florida Gainesville, Florida, United States, 32610 United States, Georgia Emory University Decatur, Georgia, United States, 30033 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Maine Maine Medical Center Portland, Maine, United States, 04102 United States, Michigan Children's Hospital of Michigan Detroit, Michigan, United States, 48201 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 United States, Ohio University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15224 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Canada The Hospital for Sick Children Toronto, Canada, M5G 1Hs Less << |
| NCT00006240 | Leukemia | Phase 2 | Completed | - | United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 National Heart, Lung, and Blood Institute Bethesda, Maryland, United States, 20892 United States, New York Mount Sinai Medical Center, NY New York, New York, United States, 10029 United States, Pennsylvania University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15213-3489 Less << |
| NCT00005639 | Lymphoma Smal... More >>l Intestine Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << | Phase 1 | Completed | - | United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Less << |
| NCT01881984 | Medium-chain Acyl-CoA Dehydrog... More >>enase (MCAD) Deficiency Less << | Phase 1 | Completed | - | United States, Pennsylvania ... More >> Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15224 Less << |
| NCT00006019 | Leukemia Lung... More >> Cancer Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Prostate Cancer Less << | Phase 2 | Completed | - | United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less << |
| NCT02323100 | Cystic Fibrosis | Phase 1 Phase 2 | Recruiting | April 2020 | United States, Alabama ... More >> University of Alabama at Birmingham Not yet recruiting Birmingham, Alabama, United States, 35294-0006 Contact: Steven M Rowe, MD, MSPH 205-934-9640 smrowe@uab.edu Principal Investigator: Steven M Rowe, MD, MSPH United States, Colorado National Jewish Health Recruiting Denver, Colorado, United States, 80206 Contact: Connie StClair 303-270-2321 shiven@njhealth.org Principal Investigator: Noah Lechtzin, MD Sub-Investigator: Peter Mogazel, MD, PhD United States, Pennsylvania Children's Hospital of Philadelphia Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Ron Rubenstein, MD, PhD 215-590-1281 rrubenst@mail.med.upenn.edu Principal Investigator: Ron Rubenstein, MD, PhD Less << |
| NCT00016744 | Cystic Fibrosis | Phase 1 Phase 2 | Completed | - | - |
| NCT01881984 | - | Completed | - | - | |
| NCT00006450 | Brain Tumor | Phase 2 | Completed | - | United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less << |
| NCT00590538 | - | Terminated(12/15/2008 Voluntar... More >>ily placed on inactive status-requested by the PI) Less << | - | - | |
| NCT00590538 | Cystic Fibrosis | Phase 1 Phase 2 | Terminated(12/15/2008 Voluntar... More >>ily placed on inactive status-requested by the PI) Less << | - | United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less << |
| NCT00992459 | Urea Cycle Disorders | Phase 3 | Completed | - | - |
| NCT00977600 | Healthy | Phase 1 | Completed | - | Ukraine ... More >> Medical Sanitary Division #2 Kharkiv, Ukraine, 61011 Less << |
| NCT00439569 | Spinal Muscular Atrophy Type I... More >>I Spinal Muscular Atrophy Type III Less << | Phase 1 Phase 2 | Terminated(Due to poor complia... More >>nce with study drug administration.) Less << | - | United States, California ... More >> Stanford University Medical Center, 300 Pasteur Drive, Room A343 Stanford, California, United States, 94305-5235 United States, Missouri Washington University Medical School, Washington University, 660 S. Euclid Avenue, Box 8111 St. Louis, Missouri, United States, 63110 United States, New York Columbia University, 180 Fort Washington Avenue, 5th Floor New York, New York, United States, 10032 United States, Pennsylvania The Children's Hospital of Philadelphia, Clinical Trials Office, A-230, 34th St. and Civic Center Boulevard Philadelphia, Pennsylvania, United States, 19104-4399 United States, Texas University of Texas Southwestern Medical Center at Dallas, Division of Pediatric Neurology, Children's Medical Center of Dallas, Ambulatory Care Pavilion, 2350 Stemmons Freeway, Suite #5074 Dallas, Texas, United States, 75207 Less << |
| NCT00001565 | Brain Neoplasms ... More >> Neuroblastoma Less << | Phase 1 | Completed | - | United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less << |
| NCT00004871 | Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << | Phase 1 | Completed | - | United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less << |
| NCT00439569 | - | Terminated(Due to poor complia... More >>nce with study drug administration.) Less << | - | - | |
| NCT00992459 | - | Completed | - | - | |
| NCT00002909 | Lymphoma Unsp... More >>ecified Adult Solid Tumor, Protocol Specific Less << | Phase 1 | Completed | - | United States, Maryland ... More >> Johns Hopkins Oncology Center Baltimore, Maryland, United States, 21287 Less << |
| NCT01949766 | - | - | - | - | |
| NCT00002796 | Mucinous Adenocarcinoma of the... More >> Colon Mucinous Adenocarcinoma of the Rectum Recurrent Colon Cancer Recurrent Rectal Cancer Signet Ring Adenocarcinoma of the Colon Signet Ring Adenocarcinoma of the Rectum Stage IVA Colon Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Rectal Cancer Less << | Phase 1 Phase 2 | Terminated(Administratively co... More >>mplete.) Less << | - | United States, New York ... More >> Mount Sinai Medical Center New York, New York, United States, 10029 Less << |
| NCT00439218 | Spinal Muscular Atrophy Type I | Phase 1 Phase 2 | Terminated(Extremely slow enro... More >>llment) Less << | - | United States, California ... More >> Stanford University Medical Center, 300 Pasteur Drive, Room A343 Stanford, California, United States, 94305-5235 United States, Massachusetts Children's Hospital, Boston, 300 Longwood Avenue, Fegan 11 Boston, Massachusetts, United States, 02115 United States, New York Columbia University, 180 Fort Washington Avenue, 5th Floor New York, New York, United States, 10032 United States, Pennsylvania The Children's Hospital of Philadelphia, Clinical Trials Office, A-230, 34th St. and Civic Center Boulevard Philadelphia, Pennsylvania, United States, 19104-4399 United States, Texas University of Texas Southwestern Medical Center at Dallas, Division of Pediatric Neurology, Children's Medical Center of Dallas, Ambulatory Care Pavilion, 2350 Stemmons Freeway, Suite #5074 Dallas, Texas, United States, 75207 Less << |
| NCT03335488 | Urea Cycle Disorder | Phase 4 | Recruiting | March 31, 2020 | United States, New York ... More >> Mount Sinai School of Medicine Recruiting New York, New York, United States, 10029 Contact: Dr. George Diaz, M.D., PhD. 212-241-0858 George.Diaz@mssm.edu Contact: Luca Fierro 212 659 1477 luca.fierro@mssm.edu Principal Investigator: Dr. George Diaz, M.D., PhD. United States, Ohio University Hospitals Case Medical Center Recruiting Cleveland, Ohio, United States, 44106-6005 Contact: Dr. Jirair Bedoyan, MD 216-844-7124 Jirair.Bedoyan@UHhospitals.org Contact: Audrey Lynn 216 844 7124 audrey.lynn@UHhospitals.org United States, Pennsylvania Children's Hospital of Pittsburgh of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15224 Contact: Dr. Gerard Vockley, MD, PhD 412-692-7530 Jennifer.baker@chp.edu Contact: Jennifer Baker 412-692-7530 Jennifer.baker@chp.edu Principal Investigator: Dr. Gerard Vockley, MD, PhD United States, Utah University of Utah Recruiting Salt Lake City, Utah, United States, 84132 Contact: Dr. Nicola Longo, M.D., PhD. 801-587-3605 Nicola.Longo@hsc.utah.edu Contact: Carrie Bailey 801 587 3605 Carrie.Bailey@hsc.utah.edu Principal Investigator: Dr. Nicola Longo, M.D., PhD. Belgium Cliniques Universitaires Saint-Luc Recruiting Brussels, Belgium, 1200 Contact: Prof. Etienne Sokal, MD 32 2 764 13 87 etienne.sokal@uclouvain.be Contact: Julia Versavau 32 2 764 19 33 julia.versavau@uclouvain.be Principal Investigator: Prof. Etienne Sokal, MD Spain Hospital Materno-Infantil (HRU Carlos Haya) Recruiting Málaga, Andalucia, Spain, 29006 Contact: Dr. Javier Blasco-Alonso, MD 34 951 29 21 91 javierblascoalonso@yahoo.es Contact: Almudena Frias 34 951 29 21 91 Principal Investigator: Dr. Javier Blasco-Alonso Hospital Clinico Universitario de Santiago Recruiting Santiago de Compostela, Galicia, Spain, 15706 Contact: Dr. Maria Luz Couce-Pico, MD 34 981 950 162 maria.luz.couce.pico@sergas.es Contact: Maria Teresa Oreiro-Garcia 34 981 955 627 maria.teresa.oreiro.garcia@sergas.es Principal Investigator: Dr. Maria Luz Couce-Pico, MD Hospital Universitario de Cruces Recruiting Barakaldo, Vizcaya, Spain, 48903 Contact: Dr. Luis Jose Aldamiz-Echevar Azuara, MD 34 94 600 6327 LUISJOSE.ALDAMIZ-ECHEVARAZUARA@osakidetza.net Contact: Fernando Olatz 34 94 600 6327 fernando.andradelodeiro@osakidetza.eus Principal Investigator: Dr. Luis Jose Aldamiz-Echevar Azuara, MD Switzerland Universitätsspital, Inselspital Bern Recruiting Bern, Switzerland, 3010 Contact: Matthias Gautchshi,, MD 41 (0)31 632 01 47 Matthias.Gautschi@insel.ch Contact: Alexandra Nuoffer +41 (0)31 632 51 37 alexandra.nuoffer@insel.ch Principal Investigator: Dr. Matthias Gautchshi, MD University Children's Hospital Recruiting Zurich, Switzerland, 75, 8032 Contact: Prof Johannes Häberle, MD 41- 44-266-7111 johannes.haeberle@kispi.uzh.ch Contact: Ms. Doris Anzengruber 41- 44-266-7722 Doris.Anzengruber@kispi.uzh.ch Principal Investigator: Prof Johannes Häberle, MD Less << |
| NCT00528268 | Spinal Muscular Atrophy | Phase 1 Phase 2 | Completed | - | United States, Utah ... More >> University of Utah Salt Lake City, Utah, United States, 84132 Less << |
| NCT00439218 | - | Terminated(Extremely slow enro... More >>llment) Less << | - | - | |
| NCT01784718 | - | - | - | - | |
| NCT00528268 | - | Completed | - | - | |
| NCT01702974 | HIV Infection | Phase 2 | Completed | - | Ethiopia ... More >> Black Lion Hospital (BLH), Addis Ababa University, Faculty of Medicine Addis Ababa, Lideta sub city, Ethiopia Less << |
| NCT00107770 | Amyotrophic Lateral Sclerosis | Phase 1 Phase 2 | Completed | - | United States, Iowa ... More >> VA Medical Center, Iowa City Iowa City, Iowa, United States, 52246-2208 United States, Kentucky VA Medical Center, Lexington Lexington, Kentucky, United States, 40502 United States, Maryland VA Maryland Health Care System, Baltimore Baltimore, Maryland, United States, 21201 United States, Massachusetts Edith Nourse Rogers Memorial Veterans Hospital, Bedford Bedford, Massachusetts, United States, 01730 VA Medical Center, Jamaica Plain Campus Boston, Massachusetts, United States, 02130 United States, New York VA Medical Center, Syracuse Syracuse, New York, United States, 13210 United States, North Carolina VA Medical Center, Durham Durham, North Carolina, United States, 27705 United States, Ohio VA Medical Center, Cincinnati Cincinnati, Ohio, United States, 45220 United States, Pennsylvania VA Pittsburgh Health Care System Pittsburgh, Pennsylvania, United States, 15240 United States, Texas Michael E. DeBakey VA Medical Center (152) Houston, Texas, United States, 77030 Less << |
| NCT00533559 | Diabetes Insu... More >>lin Resistance Less << | Phase 4 | Completed | - | Canada, Ontario ... More >> Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Less << |
| NCT01698476 | Pulmonary Tuberculosis (TB) | Phase 2 | Completed | - | Ethiopia ... More >> Black Lion Hospital (BLH), Addis Ababa University, Faculty of Medicine Addis Ababa, Lideta sub city, Ethiopia Less << |
| NCT00947544 | Urea Cycle Disorders | Phase 2 | Completed | - | United States, California ... More >> UCLA Los Angeles, California, United States, 90095 United States, District of Columbia The George Washington DC Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15201 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Canada, Ontario The Hospital for Sick Children Toronto, Ontario, Canada, M5G1X8 Less << |
| NCT01580007 | Pulmonary Tuberculosis | Phase 2 | Completed | - | Bangladesh ... More >> National Institute of Diseases of Chest and Hospital (NIDCH) Dhaka, Bangladesh, 1212 Less << |
| NCT00947544 | - | Completed | - | - | |
| NCT00345605 | Argininosuccinic Aciduria ... More >> Amino Acid Metabolism, Inborn Errors Urea Cycle Disorders Less << | Phase 2 | Completed | - | United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less << |
| NCT00345605 | - | Completed | - | - | |
| NCT00551200 | Urea Cycle Disorders | Phase 2 | Completed | - | United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 Less << |
| NCT03734263 | Pyruvate Dehydrogenase Complex... More >> Deficiency Less << | Phase 1 Phase 2 | Recruiting | October 1, 2019 | Italy ... More >> Federico II University Recruiting Napoli, Italy, 80131 Contact: Nicola Brunetti-Pierri +390817463288 brunetti@tigem.it Less << |
| NCT01096095 | Spinocerebellar Ataxia Type 3 | Phase 2 | Withdrawn(Regulatory authoriti... More >>es did not allow the entrance of the study drug in the country) Less << | July 2011 | Brazil ... More >> Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil, 90.035-903 Less << |
| NCT02111200 | Urea Cycle Disorders, Inborn | Not Applicable | Completed | - | United States, Texas ... More >> Children's Nutrition Research Center/Baylor College of Medicine Houston, Texas, United States, 77030 Less << |
| NCT01529060 | Maple Syrup Urine Disease | Phase 2 Phase 3 | Active, not recruiting | December 2017 | United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less << |
| NCT02111200 | - | Completed | - | - | |
| NCT00551200 | - | Completed | - | - | |
| NCT00212316 | Huntington's Disease | Phase 2 | Completed | - | United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States United States, California University of California—San Diego San Diego, California, United States United States, Iowa University of Iowa Hospital and Clinics Iowa City, Iowa, United States United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States United States, Maryland Johns Hopkins University Baltimore, Maryland, United States United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States United States, New York Columbia University New York, New York, United States University of Rochester Rochester, New York, United States Less << |
| NCT02046434 | Parkinson's Disease | Phase 1 | Active, not recruiting | September 2018 | United States, Colorado ... More >> University of Colorado Denver Anschutz Medical Center Aurora, Colorado, United States, 80045 Less << |
| Bio Calculators | ||||
| Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
5.37mL 1.07mL 0.54mL |
26.86mL 5.37mL 2.69mL |
53.71mL 10.74mL 5.37mL |
|